Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

Ann Rheum Dis. 2022 Aug;81(8):e154. doi: 10.1136/annrheumdis-2020-218259. Epub 2020 Jul 9.
No abstract available

Keywords: arthritis, rheumatoid; cardiovascular diseases; hydroxychloroquine; outcome assessment, health care.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimalarials* / adverse effects
  • COVID-19*
  • Chloroquine
  • Fear
  • Humans
  • Hydroxychloroquine / adverse effects

Substances

  • Antimalarials
  • Hydroxychloroquine
  • Chloroquine